Table of Contents
DOYLESTOWN, Pa. — ProPhase Labs Inc. has launched Cold-EEZE Cold Remedy Daytime/Nighttime QuickMelt tablets.
The company said Monday that the new product marks its first-ever daytime/nighttime cold remedy.
Each QuickMelt tablet is designed to dissolve quickly in the mouth without water and delivers the same amount of cold remedy (zinc gluconate) in Cold-EEZE Lozenges. The nondrowsy Daytime QuickMelt tablets help shorten a cold, while the Nighttime QuickMelt tablets are a combination product formulated to shorten a cold and facilitate sleep. The Nighttime tablets contain natural extra-strength chamomile and melatonin and are non-habit-forming.
Each package comes with 18 Daytime QuickMelt tablets and six Nighttime QuickMelt tablets.
"Our new Cold-EEZE Daytime/Nighttime QuickMelts are an exciting new way to provide relief to our consumers," stated Ted Karkus, chairman and chief executive officer of ProPhase Labs. "Following the popularity of our Cold-EEZE Lozenges and Cold-EEZE Oral Spray, we felt the next step was to offer our consumers a cold remedy product that provides nighttime relief. Retailers have responded positively and aggressively in accepting our new product introduction. Our QuickMelts will be sold through nearly all national retailers that carry our Cold-EEZE Lozenges."
ProPhase also announced Monday that Cold-EEZE Oral Spray has gone from an initial distribution in the 2011-12 cough/cold season to full national distribution for the upcoming 2012-13 cough/cold season. Two sprays of the product are designed to deliver the same amount of cold remedy (zinc gluconate) as in one Cold-EEZE Lozenge.
